View Past PerformanceIofina バランスシートの健全性財務の健全性 基準チェック /66Iofinaの総株主資本は$55.7M 、総負債は$6.5Mで、負債比率は11.7%となります。総資産と総負債はそれぞれ$79.2Mと$23.5Mです。 Iofinaの EBIT は$8.7Mで、利息カバレッジ比率37です。現金および短期投資は$11.7Mです。主要情報11.68%負債資本比率US$6.50m負債インタレスト・カバレッジ・レシオ37x現金US$11.73mエクイティUS$55.68m負債合計US$23.52m総資産US$79.20m財務の健全性に関する最新情報更新なしすべての更新を表示Recent updatesお知らせ • May 05Iofina plc, Annual General Meeting, Jun 09, 2026Iofina plc, Annual General Meeting, Jun 09, 2026. Location: the offices of canaccord genuity, 88 wood street, ec2v 7qr, london United Kingdomお知らせ • Apr 16Iofina plc Provides Production Guidance for the First Half of Fiscal Year 2026Iofina plc provided production guidance for the first half of fiscal year 2026. For the period, The Company now expects to exceed the previous H1 2026 production guidance of 325MT-355MT. Based on the current trends, the Company is now anticipating H1 2026 production to be closer to 385MT.お知らせ • Jan 13Iofina plc Provides Earnings Guidance for 2025 and Production Guidance for the First Half of 2026Iofina plc provided earnings guidance for 2025 and production guidance for the first half of 2026. For the 2025, the company's revenue are projected to surpass $65 million. For the first half of 2026, the company expects to produce between 325 MT-355 MT of crystalline iodine in H1 2026 (H1 2025: 305.5MT).お知らせ • Dec 14Iofina plc Announces the Proposed Appointment of Tim Hughes as a Non-Executive Director, Effective 1 January 2026Iofina plc announced the proposed appointment of Tim Hughes as a Non-Executive Director, to take effect from 1 January 2026. Tim has significant experience in general management in the specialty chemical industry as well as corporate and sustainability matters. Tim was a member of the Executive Committee of Synthomer plc for 11 years until 2023 as divisional director for the industrial specialties global business, which included the company's specialty iodine business, before then becoming President of Corporate Development, where he was responsible for investor relations, external affairs and the development of the company's sustainability strategy. Prior to Synthomer, Tim led the Urethane Technologies joint venture business for Chemtura Corporation and spent 14 years in business leadership and marketing roles at Courtaulds plc. Tim is based in the UK and holds a BSc in Chemistry from the University of Manchester and an MBA from Cranfield University. Concurrent with his appointment, Tim will also be appointed as a member of Iofina's Audit and Remuneration Committees. Timothy John Hughes, age 61, is currently or has been a Director of the following companies within the past five years: Current Directorships at Catalyst Science Discovery Centre and Museum Trust Limited, Synthomer (UK) Limited and Chemical Industries Association Limited and Previous Directorships at Synthomer (UK) Limited.お知らせ • Oct 17Iofina plc Provides Production Guidance for the Second Half of 2025Iofina plc provided production guidance for the second half of 2025. For the period, the company expects production is on track to be within the production range of 400 MT - 440 MT.お知らせ • May 15Iofina plc, Annual General Meeting, Jun 09, 2025Iofina plc, Annual General Meeting, Jun 09, 2025. Location: the offices of canaccord genuity, 88 wood street, ec2v 7qr, london United Kingdomお知らせ • Apr 19Iofina plc Revises Production Guidance for First Half of 2025Iofina plc revised production guidance for first half of 2025. For the period, the company now expects total iodine production for first half of 2025 to be closer to 300MT compared to the previously guided range of 320MT-355MT. The company will provide a further update on Iofina Resources' production as part of its year-end 2024 financial reporting.お知らせ • Jul 16Iofina plc Provides Production Guidance for the Second Half of 2024Iofina plc provided production guidance for the second half of 2024. The company anticipates production in the second half of 2024 to be in the range of 355 MT - 380 MT.お知らせ • May 17Iofina plc, Annual General Meeting, Jun 13, 2024Iofina plc, Annual General Meeting, Jun 13, 2024. Location: the offices of canaccord genuity, 88 wood street, ec2v 7qr, london United Kingdomお知らせ • May 16Iofina plc Announces Resignation of William ("Bill") D. Bellamy as DirectorIofina plc announced that Dr. William ("Bill") D. Bellamy, Chair of the Remuneration Committee, will retire as a Director of the Company at the close of the AGM and is therefore not being submitted for re-appointment in the business of the meeting.お知らせ • Jan 15Iofina plc Provides Market Update Regarding Its Activities During Fourth Quarter 2023 and Outlines Expectations for 2024Iofina plc provided a market update regarding its activities during Fourth Quarter 2023 and outlines expectations for 2024. With IO#9 plant operating at an improved production rate in the second half of Fourth Quarter 2023,crystalline iodine production across Iofina Resources' six plants for the last quarter increased year over year by 16% to 160.9 metric tonnes (MT). Total production during the second half was 317.8MT, which aligned with the Company's guidance that H2 2023 production would either be at the bottom or very marginally below the forecast range of 325-350MT. This nevertheless represents a13% increase over production of 282.0MT for H2 2022. Total crystalline iodine production in 2023 was up 8% to 559.3MT, compared to 2022 production levels of 516MT. The iodine spot price softened by circa five percent over H2 2023 towards mid-to-upper sixties dollars per kilogram as prices have settled from historically high levels. Moving into 2024, the market fundamentals of the iodine business remain strong and Iofina currently expects the spot price to remain at present levels for the foreseeable future. Demand for the Company's crystalline iodine remained robust during the final quarter, whilst sales of iodine derivatives had mixed results. Regarding non-iodine products, sales of a key product mainly used in the semiconductor industry improved significantly in the second half of the year after a slower-than-anticipated first half. Moving into 2024, Iofina Resources expects to produce 275MT - 295MT of crystalline iodine during the first half (H1 2023: 242MT), which would result in a 13% to 22% increase over H1 2023. The Company reiterates that H1 iodine plant production has historically always been lower than H2 production due to the effect of lower temperatures on production in the winter months, whereas H2 production benefits from greater output in the warmer summer period. Encouraging progress has also been made regarding construction plans for IO#10 plant, with groundwork at the site scheduled to commence this week. The Company expects IO#10 iodine production to commence in Third Quarter 2024 and will update on progress as appropriate. Negotiations continue to progress well with both current and potential new brine supply partners for IO#11, and the Company continues to explore options in its current core area and other new areas for next iodine production facilities. In terms of new products, Iofina Chemical will beadding to its iodine derivatives product range in H1 2024, including an existing product in the market for which there is strong demand. The Company also expects to increase sales of its crystalline iodine to customers in Europe in 2024 through existing and new relationships. The Group is committed to operating its facilities with a safety-first approach and is proud to report that Iofina has had no lost time incidents since April 2021.お知らせ • Oct 20Iofina plc Provides Production Guidance for the Second Half of 2023Iofina plc provided production guidance for the second half of 2023. the company expected second half production is trending towards the lower end of company's forecast of 325-350 MT.お知らせ • Sep 12Iofina plc Provides Production Guidance for the Second Half of 2023Iofina plc provided production guidance for the second half of 2023. With the addition of IO#9 output, second half 2023 production is on track to meet the 325-350MT target.お知らせ • May 09Iofina plc, Annual General Meeting, Jun 14, 2023Iofina plc, Annual General Meeting, Jun 14, 2023, at 09:00 Coordinated Universal Time. Location: Canaccord Genuity, 88 Wood Street London United Kingdom Agenda: To receive and adopt the reports of the directors and the auditors and the audited financial statements of the Company for the year ended 31 December 2022; to re-appoint Malcolm Lewin as director; to re-appoint Mary Fallin Christensen as a director; to re-appoint UHY Hacker Young LLP as the Company's auditors to hold office from the conclusion of the AGM to the conclusion of the next meeting at which the accounts are laid before the Company and to authorise the directors to determine remuneration.財務状況分析短期負債: IOFN.Fの 短期資産 ( $39.0M ) が 短期負債 ( $14.8M ) を超えています。長期負債: IOFN.Fの短期資産 ( $39.0M ) が 長期負債 ( $8.7M ) を上回っています。デット・ツー・エクイティの歴史と分析負債レベル: IOFN.F総負債よりも多くの現金を保有しています。負債の削減: IOFN.Fの負債対資本比率は、過去 5 年間で60.2%から11.7%に減少しました。債務返済能力: IOFN.Fの負債は 営業キャッシュフロー によって 十分にカバー されています ( 169.6% )。インタレストカバレッジ: IOFN.Fの負債に対する 利息支払い は EBIT ( 37 x coverage) によって 十分にカバーされています。貸借対照表健全な企業の発掘7D1Y7D1Y7D1YMaterials 業界の健全な企業。View Dividend企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/06/12 01:39終値2026/06/10 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Iofina plc 1 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。2 アナリスト機関Alexander BrooksCanaccord GenuityStuart JoynerInvestec Bank plc (UK)
お知らせ • May 05Iofina plc, Annual General Meeting, Jun 09, 2026Iofina plc, Annual General Meeting, Jun 09, 2026. Location: the offices of canaccord genuity, 88 wood street, ec2v 7qr, london United Kingdom
お知らせ • Apr 16Iofina plc Provides Production Guidance for the First Half of Fiscal Year 2026Iofina plc provided production guidance for the first half of fiscal year 2026. For the period, The Company now expects to exceed the previous H1 2026 production guidance of 325MT-355MT. Based on the current trends, the Company is now anticipating H1 2026 production to be closer to 385MT.
お知らせ • Jan 13Iofina plc Provides Earnings Guidance for 2025 and Production Guidance for the First Half of 2026Iofina plc provided earnings guidance for 2025 and production guidance for the first half of 2026. For the 2025, the company's revenue are projected to surpass $65 million. For the first half of 2026, the company expects to produce between 325 MT-355 MT of crystalline iodine in H1 2026 (H1 2025: 305.5MT).
お知らせ • Dec 14Iofina plc Announces the Proposed Appointment of Tim Hughes as a Non-Executive Director, Effective 1 January 2026Iofina plc announced the proposed appointment of Tim Hughes as a Non-Executive Director, to take effect from 1 January 2026. Tim has significant experience in general management in the specialty chemical industry as well as corporate and sustainability matters. Tim was a member of the Executive Committee of Synthomer plc for 11 years until 2023 as divisional director for the industrial specialties global business, which included the company's specialty iodine business, before then becoming President of Corporate Development, where he was responsible for investor relations, external affairs and the development of the company's sustainability strategy. Prior to Synthomer, Tim led the Urethane Technologies joint venture business for Chemtura Corporation and spent 14 years in business leadership and marketing roles at Courtaulds plc. Tim is based in the UK and holds a BSc in Chemistry from the University of Manchester and an MBA from Cranfield University. Concurrent with his appointment, Tim will also be appointed as a member of Iofina's Audit and Remuneration Committees. Timothy John Hughes, age 61, is currently or has been a Director of the following companies within the past five years: Current Directorships at Catalyst Science Discovery Centre and Museum Trust Limited, Synthomer (UK) Limited and Chemical Industries Association Limited and Previous Directorships at Synthomer (UK) Limited.
お知らせ • Oct 17Iofina plc Provides Production Guidance for the Second Half of 2025Iofina plc provided production guidance for the second half of 2025. For the period, the company expects production is on track to be within the production range of 400 MT - 440 MT.
お知らせ • May 15Iofina plc, Annual General Meeting, Jun 09, 2025Iofina plc, Annual General Meeting, Jun 09, 2025. Location: the offices of canaccord genuity, 88 wood street, ec2v 7qr, london United Kingdom
お知らせ • Apr 19Iofina plc Revises Production Guidance for First Half of 2025Iofina plc revised production guidance for first half of 2025. For the period, the company now expects total iodine production for first half of 2025 to be closer to 300MT compared to the previously guided range of 320MT-355MT. The company will provide a further update on Iofina Resources' production as part of its year-end 2024 financial reporting.
お知らせ • Jul 16Iofina plc Provides Production Guidance for the Second Half of 2024Iofina plc provided production guidance for the second half of 2024. The company anticipates production in the second half of 2024 to be in the range of 355 MT - 380 MT.
お知らせ • May 17Iofina plc, Annual General Meeting, Jun 13, 2024Iofina plc, Annual General Meeting, Jun 13, 2024. Location: the offices of canaccord genuity, 88 wood street, ec2v 7qr, london United Kingdom
お知らせ • May 16Iofina plc Announces Resignation of William ("Bill") D. Bellamy as DirectorIofina plc announced that Dr. William ("Bill") D. Bellamy, Chair of the Remuneration Committee, will retire as a Director of the Company at the close of the AGM and is therefore not being submitted for re-appointment in the business of the meeting.
お知らせ • Jan 15Iofina plc Provides Market Update Regarding Its Activities During Fourth Quarter 2023 and Outlines Expectations for 2024Iofina plc provided a market update regarding its activities during Fourth Quarter 2023 and outlines expectations for 2024. With IO#9 plant operating at an improved production rate in the second half of Fourth Quarter 2023,crystalline iodine production across Iofina Resources' six plants for the last quarter increased year over year by 16% to 160.9 metric tonnes (MT). Total production during the second half was 317.8MT, which aligned with the Company's guidance that H2 2023 production would either be at the bottom or very marginally below the forecast range of 325-350MT. This nevertheless represents a13% increase over production of 282.0MT for H2 2022. Total crystalline iodine production in 2023 was up 8% to 559.3MT, compared to 2022 production levels of 516MT. The iodine spot price softened by circa five percent over H2 2023 towards mid-to-upper sixties dollars per kilogram as prices have settled from historically high levels. Moving into 2024, the market fundamentals of the iodine business remain strong and Iofina currently expects the spot price to remain at present levels for the foreseeable future. Demand for the Company's crystalline iodine remained robust during the final quarter, whilst sales of iodine derivatives had mixed results. Regarding non-iodine products, sales of a key product mainly used in the semiconductor industry improved significantly in the second half of the year after a slower-than-anticipated first half. Moving into 2024, Iofina Resources expects to produce 275MT - 295MT of crystalline iodine during the first half (H1 2023: 242MT), which would result in a 13% to 22% increase over H1 2023. The Company reiterates that H1 iodine plant production has historically always been lower than H2 production due to the effect of lower temperatures on production in the winter months, whereas H2 production benefits from greater output in the warmer summer period. Encouraging progress has also been made regarding construction plans for IO#10 plant, with groundwork at the site scheduled to commence this week. The Company expects IO#10 iodine production to commence in Third Quarter 2024 and will update on progress as appropriate. Negotiations continue to progress well with both current and potential new brine supply partners for IO#11, and the Company continues to explore options in its current core area and other new areas for next iodine production facilities. In terms of new products, Iofina Chemical will beadding to its iodine derivatives product range in H1 2024, including an existing product in the market for which there is strong demand. The Company also expects to increase sales of its crystalline iodine to customers in Europe in 2024 through existing and new relationships. The Group is committed to operating its facilities with a safety-first approach and is proud to report that Iofina has had no lost time incidents since April 2021.
お知らせ • Oct 20Iofina plc Provides Production Guidance for the Second Half of 2023Iofina plc provided production guidance for the second half of 2023. the company expected second half production is trending towards the lower end of company's forecast of 325-350 MT.
お知らせ • Sep 12Iofina plc Provides Production Guidance for the Second Half of 2023Iofina plc provided production guidance for the second half of 2023. With the addition of IO#9 output, second half 2023 production is on track to meet the 325-350MT target.
お知らせ • May 09Iofina plc, Annual General Meeting, Jun 14, 2023Iofina plc, Annual General Meeting, Jun 14, 2023, at 09:00 Coordinated Universal Time. Location: Canaccord Genuity, 88 Wood Street London United Kingdom Agenda: To receive and adopt the reports of the directors and the auditors and the audited financial statements of the Company for the year ended 31 December 2022; to re-appoint Malcolm Lewin as director; to re-appoint Mary Fallin Christensen as a director; to re-appoint UHY Hacker Young LLP as the Company's auditors to hold office from the conclusion of the AGM to the conclusion of the next meeting at which the accounts are laid before the Company and to authorise the directors to determine remuneration.